Hinge Health is trading 11.9% up at $88.90 after reporting strong second-quarter 2026 results and raising its full-year guidance.
- The company posted approximately 53% year-over-year revenue growth and expanded operating margins, signaling what analysts describe as a major profitability inflection.
- Hinge Health announced a $105 million acquisition of Cylinder Health to enter the gastrointestinal care market, representing a significant strategic expansion beyond musculoskeletal health.